Position in BBIO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$53,210,224
+$21,732,302 QoQ
Shares Held
714,423
+68.5% QoQ
Ownership
0.365%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#57
of 472 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BBIO Over Time
Shares Held
Position Value (USD)
Derivatives in BBIO
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$1,519,392
PutShares
20,400
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BARCLAYS PLC holds $1,710,275,600 across 455 Biotechnology names. BBIO ranks #6 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
733,274 | $364,239,192 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
256,192 | $159,745,957 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
1,603,136 | $127,112,653 | |
| 4 | ARGX |
Argenx SE
|
134,427 | $124,717,337 | |
| 5 | MRNA |
Moderna, Inc.
|
1,035,126 | $72,489,872 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
This page
|
714,423 | $53,210,224 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
957,848 | $52,624,168 | |
| 8 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
431,753 | $42,087,281 |
All Filings in BBIO
Export CSV
34 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $53,210,224 | 714,423 | Shares | Defined | 2026-08-14 | |
| 2026-06-30 | $1,519,392 | 20,400 | Put | Defined | 2026-08-14 | |
| 2026-03-31 | $31,477,922 | 423,888 | Shares | Defined | 2026-05-15 | |
| 2026-03-31 | $1,514,904 | 20,400 | Put | Defined | 2026-05-15 | |
| 2025-12-31 | $1,560,396 | 20,400 | Put | Sole | 2026-02-13 | |
| 2025-12-31 | $47,620,761 | 622,575 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,059,576 | 20,400 | Put | Sole | 2026-03-31 | |
| 2025-09-30 | $37,368,127 | 719,448 | Shares | Sole | 2026-03-31 | |
| 2025-06-30 | $40,309,047 | 933,512 | Shares | Sole | 2026-02-27 | |
| 2025-03-31 | $13,442,128 | 388,838 | Shares | Sole | 2026-03-17 | |
| 2024-12-31 | $12,279,674 | 447,510 | Shares | Sole | 2026-03-19 | |
| 2024-09-30 | $13,875,903 | 545,008 | Shares | Sole | 2026-03-31 | |
| 2024-06-30 | $10,468,002 | 413,265 | Shares | Sole | 2026-03-23 | |
| 2024-03-31 | $927,600 | 30,000 | Call | Sole | 2026-03-24 | |
| 2024-03-31 | $1,128,580 | 36,500 | Put | Sole | 2026-03-24 | |
| 2024-03-31 | $12,527,794 | 405,168 | Shares | Sole | 2026-03-24 | |
| 2023-12-31 | $29,956,073 | 742,038 | Shares | Sole | 2026-03-24 | |
| 2023-12-31 | $262,405 | 6,500 | Put | Sole | 2026-03-24 | |
| 2023-09-30 | $12,695,572 | 481,440 | Shares | Sole | 2026-03-26 | |
| 2023-06-30 | $10,133,620 | 589,164 | Shares | Sole | 2026-03-27 | |
| 2023-03-31 | $11,123,173 | 670,879 | Shares | Sole | 2026-03-30 | |
| 2023-03-31 | $34,818 | 2,100 | Call | Sole | 2026-03-30 | |
| 2022-12-31 | $9,158,363 | 1,201,885 | Shares | Sole | 2026-03-30 | |
| 2022-09-30 | $3,244,584 | 326,417 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $267,297 | 29,438 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $432,247 | 42,586 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $3,237,154 | 194,074 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $4,197,957 | 89,566 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $3,841,698 | 63,020 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $6,173,490 | 100,219 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $2,591,817 | 36,448 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $1,252,117 | 33,372 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,483,363 | 45,488 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $851,556 | 29,364 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||